SCHEMBL19851079

SCHEMBL19851079

Sc1nc2cccnc2n1C1CCCCCCCC1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 4/20 0.54
PDE4D Q08499 4/20 0.54
ALDH1A1 P00352 2/20 0.48
TSHR P16473 1/20 0.48
HSD17B10 Q99714 1/20 0.48
TP53 P04637 2/20 0.45
MAPT P10636 2/20 0.43
MAPK1 P28482 2/20 0.43
USP2 O75604 3/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
POLB P06746 1/20 0.42
LMNA P02545 2/20 0.41
PKM P14618 1/20 0.41
GAA P10253 2/20 0.40
ALOX15 P16050 1/20 0.40
KDM4E B2RXH2 1/20 0.39
PDE10A Q9Y233 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19851114 0.86 PDE4B (0.46) PDE4BPDE4DALDH1A1TSHRHSD17B10
SCHEMBL5775573 0.82 PDE4B (0.54) PDE4BPDE4DALDH1A1TSHRHSD17B10
SCHEMBL5775620 0.82 PDE4B (0.54) PDE4BPDE4DALDH1A1TSHRHSD17B10
SCHEMBL5778683 0.82 PDE4B (0.54) PDE4BPDE4DALDH1A1TSHRHSD17B10
SCHEMBL1104426 0.80 TP53 (0.58) TP53
SCHEMBL19851122 0.77 OPRM1 (0.48) PDE4BPDE4DALDH1A1TSHRHSD17B10
SCHEMBL19851115 0.77 OPRM1 (0.48) PDE4BPDE4DALDH1A1TSHRHSD17B10
SCHEMBL16084474 0.77 PDE4B (0.52) PDE4BPDE4DALDH1A1TSHRHSD17B10
SCHEMBL14582733 0.76 PDE4B (0.49) PDE4BPDE4DALDH1A1TSHRHSD17B10
SCHEMBL5774222 0.74 PDE4B (0.59) PDE4BPDE4DALDH1A1TSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3495362-B1 IMIDAZOPYRIDINE THIOGLYCOLIC ACID DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF UNIV SHANDONG (CN) 2021-10-27 EP disclosed
US-20190225606-A1 Novel Imidazopyridine Thioglycolic Acid Derivatives as Potent Inhibitors of Human Urate Transporter 1 SHANDONG UNIVERSITY (CN) 2019-07-25 US disclosed
EP-3495362-A1 IMIDAZOPYRIDINE THIOGLYCOLIC ACID DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Shandong University (CN) 2019-06-12 EP disclosed
WO-2018023851-A1 IMIDAZOPYRIDINE THIOGLYCOLIC ACID DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 山东大学 2018-02-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190225606-A1 Novel Imidazopyridine Thioglycolic Acid Derivatives as Potent Inhibitors of Human Urate Transporter 1 SLC29A1, SLC28A1, SLC5A1 PDE4B 3788/4885PDE4D 4154/4885ALDH1A1 446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.